Mode
Text Size
Log in / Sign up
N/A N=75 Treatment

Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft Investigational Device Exemption (IDE) Study

Aortic Aneurysm, Abdominal

Enrolled (actual)
75
Serious AEs
14.7%
Results posted
Dec 2021
Primary outcome: Primary: Number of Subjects With Treatment Success — 58 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Ovation Alto Abdominal Stent Graft System (Device)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Endologix
Primary completion
Mar 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Subjects With Treatment Success
58
SECONDARY
Event Rates for Endoleaks
0; 1; 0; 34; 0; 0
SECONDARY
Number of Participants With Stent Graft Migration > 10mm
0; 0
SECONDARY
Number of Participants With AAA Enlargement > 5mm
0; 1
SECONDARY
Number of Participants With AAA Rupture
0; 0
SECONDARY
Number of Participants With Conversion to Open Repair
0; 1
SECONDARY
Number of Secondary Interventions
0; 2
SECONDARY
Number of Participants With AAA-related Mortality
0; 0
SECONDARY
Device-related Adverse Events (AEs)
0; 1; 1; 0
SECONDARY
Major Adverse Events
0; 3; 3; 0; 0; 1
SECONDARY
Number of Participants With Other Stent Graft Finding (Includes Kinking and Stent Compression)
0; 0; 0
SECONDARY
Number of Participants With Stent Fracture
0; 0; 0
SECONDARY
Adverse Events (Serious and Non-serious)
0; 0; 0; 4; 13; 0
SECONDARY
Procedure-related Adverse Event
2; 0; 3; 1; 0; 0
SECONDARY
Serious Adverse Event
0; 2; 0; 0; 0; 1

Summary

A prospective clinical evaluation of the effectiveness of the Ovation Alto Abdominal Stent Graft System when used in the treatment of subjects with abdominal aortic aneurysm (AAA).

Eligibility Criteria

Inclusion Criteria include:

  • Patient has adequate iliac/femoral access compatible with the required delivery systems.
  • Patient has non-aneurysmal proximal aortic neck.
  • Patient has non-aneurysmal distal iliac landing zone.

Exclusion Criteria include:

  • Patient has dissecting aneurysm.
  • Patient has acutely ruptured aneurysm.
  • Patient has need for emergent surgery.
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02949297). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search